B-cell Lymphoma
📧 Sign up to get email alerts when something new happens for B-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances [Phase 1, Phase 2]
A Phase I/II clinical trial evaluating CAR.70, engineered IL-15-transduced cord blood-derived natural killer (NK) cells, in combination with…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Phase 1/2 Study of STP938 for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas [Phase 1, Phase 2]
A Phase 1/2 clinical trial update for STP938 in adults with relapsed or refractory B-cell and T-cell lymphomas is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Nanobody-Based CD19/CD20 Tandem Dual CAR-T-cell Therapy of Relapsed/Refractory B-Cell Lymphoma [EARLY_Phase 1]
An early-phase study evaluating a nanobody-based tandem CD19/CD20 CAR-T-cell therapy for relapsed or refractory B-cell lymphoma; the trial i…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Mosunetuzumab Consolidation Therapy After autoSCT in r/r Aggressive B Cell Lymphoma [Phase 1]
Phase 1 clinical trial evaluating mosunetuzumab consolidation after autologous stem cell transplantation in relapsed/refractory aggressive B…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Study of 19(T2)28z1xx TRAC-Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Lymphoma [Phase 1]
This ClinicalTrials.gov update describes an ongoing Phase 1 study of 19(T2)28z1xx TRAC-CAR T cells in patients with B-cell lymphomas, includ…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Treatment of Relapsed or Refractory B-cell Lymphoma With Chimeric Antigen Receptor (CAR) T-cell Therapy Produced by a New Technology [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating a novel CAR T-cell therapy produced using a new technology for relapsed or refractory B-cell lymphoma …
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Study to Investigate Safety and Effectiveness of BGB-16673 in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies [Phase 1, Phase 2]
This is a clinical trial update for a Phase 1/2 study of BGB-16673 in combination with other agents for relapsed or refractory B-cell lympho…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin Lymphoma [Phase 1, Phase 2]
This document provides a status update on a Phase 1/2 clinical trial evaluating JNJ-90014496 in participants with B-cell non-Hodgkin lymphom…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies [Phase 1, Phase 2]
This document provides an update on a Phase 1/2 study of NX-5948 in combination with other agents for adults with B-cell malignancies. The t…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Antigen Targeted T Cell Therapy for Relapsed/Refractory B Cell Lymphomas [Phase 1, Phase 2]
This document notes a phase 1/2 trial of an antigen-targeted T cell therapy for relapsed/refractory B-cell lymphoma is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL [Phase 3]
A Phase 3 clinical trial is planned to compare NX-5948 against Pirtobrutinib in relapsed/refractory chronic lymphocytic leukemia and small l…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: U96-CAR-T-Cells For R/R B-ALL [Phase 1]
This clinical trial update reports a Phase 1 study of U96-CAR-T-Cells for relapsed or refractory B-cell acute lymphoblastic leukemia and B-c…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: CLIC-2201 for the Treatment of Relapsed/Refractory B Cell Malignancies [Phase 1]
A Phase 1 study of CLIC-2201 for relapsed/refractory B-cell malignancies is currently recruiting. The conditions covered include various B-c…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Efficacy and Safety of CD19/CD20 CAR/TRuC-T in Relapsed/Refractory B-Cell Lymphoma [Phase 1, Phase 2]
An ongoing Phase 1/2 clinical trial evaluating CD19/CD20 CAR/TRuC-T therapy for relapsed/refractory B-cell lymphoma, currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Long-Term Follow-Up of AvenCell Sponsored CAR-T Cell Clinical Trials
Long-term follow-up update on AvenCell-sponsored CAR-T cell trials for B-cell lymphoma and chronic lymphocytic leukemia with ongoing enrollm…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: A Study of Melphalan in People With Lymphoma Getting an Autologous Hematopoietic Cell Transplant [Phase 1]
A Phase 1 study evaluating the use of melphalan in lymphoma patients undergoing autologous hematopoietic cell transplantation.
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Study of Oral LOXO-338 in Patients With Advanced Blood Cancers [Phase 1]
Phase 1 study of oral LOXO-338 in advanced blood cancers is ongoing, with status listed as active but not recruiting.
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Safety and Efficacy Study of BAFF-R CAR-T Cells in Adult Subjects With CD19-Negative Relapsed or Refractory B-Cell Lymphoma [Phase 1]
Phase 1 clinical trial evaluating the safety and early efficacy of BAFF-R CAR-T cells in adults with CD19-negative relapsed or refractory B-…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Clinical Study of Oncolytic Vaccinia VIrus Delivering Targeted CD19 in Vivo CAR-T/M Therapy for Refractory/Relapsed B-cell Lymphoma [Phase 1]
A Phase 1 clinical trial evaluating an in vivo CD19-targeted CAR-T/M therapy delivered by an oncolytic vaccinia virus for refractory/relapse…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Phase I Master Protocol of Novel Combination Therapy for Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma [EARLY_Phase 1]
Phase I master protocol trial evaluating a novel combination therapy for patients with relapsed or refractory aggressive B-cell lymphomas.
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Venetoclax Plus Inotuzumab for B-ALL [Phase 1]
This is an update on a Phase 1 trial of venetoclax plus inotuzumab ozogamicin for B-cell acute lymphoblastic leukemia and B-cell lymphoma; t…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Clinical Study of Universal CD19 CAR-γδT Cell Injection in the Treatment of Adult Relapsed/Refractory B-cell Lymphoma [Phase 1]
This clinical trial update describes a Phase 1 study evaluating universal CD19 CAR-γδT cell injections for adults with relapsed or refractor…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Anti CD19 Gene Therapy for B-cell Lymphoma [NA]
A clinical trial is recruiting for an anti CD19 gene therapy to treat B-cell lymphoma.
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Universal CAR-T Cells (REVO-UWD-19) for Refractory and Relapsed B-Cell Tumors [EARLY_Phase 1]
A Phase 1 trial evaluating universal CAR-T cells (REVO-UWD-19) for refractory or relapsed B-cell malignancies is currently recruiting, spons…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Polymer-lipid Particle-delivered CAR1920 mRNA CAR-T Therapy for Relapsed/Refractory B-cell Lymphoma/Leukemia [Phase 2]
Phase 2 clinical trial evaluating polymer-lipid particle-delivered CAR1920 mRNA CAR-T therapy for relapsed/refractory B-cell lymphoma and le…